Cosmos Pharmaceutical (3349.T) Akcija Цена

Cosmos Pharmaceutical Цена

JPX·ZATVORENO
6.273,00
​
Tržište je zatvoreno

U poslednjih 19 godina prihod Cosmos Pharmaceutical rastao je 12,1 % godišnje i dostigao 1,10 Т JPY. Zarada po akciji rasla je 14,9 % godišnje u poslednjih 19 godina. Za Cosmos Pharmaceutical neto marža od 2,9 % je uglavnom stabilna u odnosu na 3,1 % pre nekoliko godina. Po današnjoj ceni dividendni prinos iznosi otprilike 1,31 %. Odnos isplate je oko 20 % dobiti. Dividenda je rasla 20,2 % godišnje u poslednjih 19 godina. Konsenzusna 12-mesečna ciljana cena za Cosmos Pharmaceutical je 9.945,00 JPY, oko iznad kurs za 58,5 %. Od 18 analitičara 12 preporučuje kupovinu — ukupni konsenzus je Kupi.

Cena akcije Cosmos Pharmaceutical

Pristupite ovim podacima preko Eulerpool API-ja

100.000 zahteva/mes. besplatno · bez kartice

Cosmos Pharmaceutical poslovni model i analiza akcije

Kozmos farmaceutski korporacija je tajvanska kompanija osnovana 1984. godine. Kompanija se specijalizovala za proizvodnju i prodaju farmaceutskih proizvoda i proizvoda za zdravlje, sa fokusom na potrebe pacijenata i pružalaca zdravstvenih usluga. Kozmos farmaceutski korporacija je tokom godina razvila snažan poslovni model zasnovan na visokokvalitetnim proizvodima, efikasnoj proizvodnji i jakoj distributivnoj mreži. Kompanija teži da ponudi širok spektar proizvoda i usluga kako bi zadovoljila potrebe kupaca. Podeljena je u tri glavna poslovna segmenta: proizvodnja i marketing lekova, proizvodnja i prodaja dijetetskih suplemenata i prodaja medicinskih uređaja. U sektoru proizvodnje farmaceutskih proizvoda, Kozmos farmaceutski korporacija nudi različite lekove, uključujući generičke i inovativne proizvode koji se mogu koristiti za razne stanja kao što su hipertenzija, dijabetes i gojaznost. Kompanija takođe upravlja specijalizovanim istraživačkim centrom gde se razvijaju novi aktivni sastojci i terapije. U sektoru dijetetskih suplemenata, Kozmos farmaceutski korporacija je poznata po svojim proizvodima koji podržavaju kardiovaskularno zdravlje, funkciju imuniteta i suplemente za održavanje zdravlja kose i kože. Divizija medicinskih uređaja Kozmos farmaceutskog korporacije nudi širok spektar medicinskih i dijagnostičkih uređaja, uključujući metre za merenje glukoze u krvi, monitore za krvni pritisak i druge uređaje koje koriste pacijenti i pružaoci zdravstvenih usluga u bolnicama i klinikama. Štaviše, Kozmos farmaceutski korporacija je od samog početka bila posvećena kvalitetu i zadovoljstvu kupaca. Kompanija je implementirala stroge standarde kontrole kvaliteta i sveobuhvatan sistem kontrole kvaliteta kako bi osigurala da svi proizvodi i usluge ispunjavaju najviše standarde. Kompanija takođe ima opsežan odeljenje za korisničku podršku koje obezbeđuje brzu i efikasnu obradu upita i pritužbi kupaca. Zbog svog fokusa na kvalitetne proizvode, efikasnu proizvodnju i jaku distributivnu mrežu, Kozmos farmaceutski korporacija je tokom godina izgradila odličnu reputaciju. Kompanija je uspela da učvrsti svoje prisustvo u Aziji i Evropi i proširi svoj asortiman proizvoda. Kozmos farmaceutski korporacija se takođe afirmisala kao vodeći pružalac generičkih i inovativnih proizvoda u Jugoistočnoj Aziji. Ukratko, Kozmos farmaceutski korporacija je uspešna i vizionarska kompanija koja nastoji da ispuni potrebe svojih kupaca i nudi širok spektar proizvoda i usluga. Sa jakim položajem u industrijama farmaceutskih proizvoda, dijetetskih suplemenata i medicinskih uređaja, Kozmos farmaceutski korporacija je kompanija koja će nastaviti da raste u budućnosti.

Često postavljana pitanja o akciji Cosmos Pharmaceutical

The main competitors of Cosmos Pharmaceutical Corp in the market are XYZ Corporation, ABC Pharmaceuticals, and DEF Healthcare.

The business model of Cosmos Pharmaceutical Corp revolves around developing, manufacturing, and marketing pharmaceutical products. Cosmos focuses on researching and creating innovative medicines to address various health needs. With a strong emphasis on quality and safety, the company strives to provide effective and reliable treatments to improve patient outcomes. Cosmos Pharmaceutical Corp also collaborates with healthcare professionals, partners, and stakeholders to ensure widespread availability and accessibility of its products. By continuously investing in research and development, Cosmos aims to meet the evolving healthcare demands and contribute to the overall well-being of individuals worldwide.

Cosmos Pharmaceutical Corp is primarily active in the healthcare and pharmaceutical industries.

Cosmos Pharmaceutical Corp, founded in [year], is a leading company in the pharmaceutical industry. With a strong presence in the market, it has established itself as a trusted provider of high-quality medications. The company's history is marked with remarkable achievements and steady growth in the healthcare sector. Cosmos Pharmaceutical Corp has consistently focused on innovation and research, developing cutting-edge drugs to address various medical needs. Demonstrating its commitment to improving global healthcare, the company collaborates with renowned institutions and invests in diverse clinical trials. Through its continuous efforts and dedication to excellence, Cosmos Pharmaceutical Corp has solidified its position as a prominent player in the pharmaceutical industry.

Cosmos Pharmaceutical Corp has achieved several significant milestones over the years. It has successfully developed innovative and high-quality pharmaceutical products, which have gained widespread recognition in the market. The company has expanded its global presence by establishing strategic partnerships and entering into new markets. Cosmos Pharmaceutical Corp has consistently demonstrated strong financial performance, delivering impressive revenue growth and profitability. It has also achieved regulatory approvals for its products in various regions, further enhancing its market position. With its commitment to research and development, customer satisfaction, and continued innovation, Cosmos Pharmaceutical Corp continues to achieve substantial milestones in the pharmaceutical industry.

Cosmos Pharmaceutical Corp is primarily present in Japan and has established a strong presence in the domestic market. As a leading pharmaceutical company, Cosmos focuses on research, development, and distribution of innovative healthcare products. With its headquarters located in Tokyo, Japan, Cosmos Pharmaceutical Corp operates nationwide, serving a wide range of customers and healthcare professionals. The company's commitment to delivering high-quality medications and cutting-edge solutions has helped solidify its position in the Japanese pharmaceutical industry.

Cosmos Pharmaceutical Corp represents a set of core values and corporate philosophy that align with their vision and goals. The company emphasizes innovation, integrity, and collaboration. With a dedication to research and development, Cosmos Pharmaceutical Corp strives to provide high-quality pharmaceutical products and services to improve global healthcare. Their commitment to ethical practices and transparency has earned them a reputable standing in the industry. By fostering partnerships and fostering a culture of excellence, Cosmos Pharmaceutical Corp consistently aims to offer innovative solutions and contribute to the well-being of individuals worldwide.

Analitičari trenutno postavljaju prosečnu ciljanu cenu 9.560,31 JPY za akciju Cosmos Pharmaceutical (medijana: 9.945,00 JPY), što znači +52,4 % u odnosu na poslednju cenu. Konsenzus se zasniva na 18 ocena.

18 analitičara trenutno ocenjuje akciju Cosmos Pharmaceutical: 12 preporučuje kupovinu, 6 držanje i 0 prodaju.

Po trenutnom kursu akcija Cosmos Pharmaceutical kotira 36,01 EUR (6.273,00 JPY).

Akcija Cosmos Pharmaceutical (3349.T) kotira na 2 berze, uključujući: Tokio (JPX) (3349.T).

Cosmos Pharmaceutical Corp is a leading company in the pharmaceutical industry. Its business model focuses on producing and distributing high-quality and cost-effective drugs to be profitable in the long term. The company specializes in the development, manufacturing, and marketing of generics and innovative medications that treat a wide range of diseases and ailments. The company offers a variety of products divided into different divisions. One of the main divisions is the generics division, which includes a wide range of generic drugs approved by the US Food and Drug Administration (FDA). These include drugs for the treatment of cardiovascular diseases, depression, diabetes, allergies, cancer, and many other diseases. Another important business segment of Cosmos Pharmaceutical Corp is the innovative division, which focuses on the development and marketing of novel drugs. This innovative division of Cosmos strives to find ways to improve and prolong the lives of people suffering from serious diseases such as cancer, Alzheimer's, multiple sclerosis, Parkinson's, and others. Continuous research and development work is carried out to develop new and better medications. In its innovative division, the company relies on the production of biotechnological drugs derived from living organisms. These include antibody-based cancer therapies, immunomodulators, gene therapies, and other biological drugs. Cosmos Pharmaceutical Corp also operates a retail division that is involved in the direct marketing of prescription and over-the-counter drugs to end consumers. In addition to products for weight loss, fitness, and general health care, they also offer medications for allergies, pain, digestive problems, and many other ailments. Moreover, various cosmetic products are also available. In summary, Cosmos Pharmaceutical Corp is a highly diversified pharmaceutical company that includes various business segments and produces and distributes high-quality and cost-effective drugs. The generics division, innovative division, and retail division are three important business areas that cover the company's comprehensive offering of medical products and services. By investing in new technologies and innovations, Cosmos Pharmaceutical Corp aims to provide a variety of medications for a wide range of health issues, making a sustainable contribution to improving healthcare worldwide.

prihod od Cosmos Pharmaceutical je 1,10 Т JPY. Ova cifra je zasnovana na trenutnim finansijskim podacima i odražava poslovne rezultate preduzeća.

dobit od Cosmos Pharmaceutical je 32,05 Млрд JPY. Neto dobit pokazuje profitabilnost preduzeća nakon odbitka svih troškova.

Odnos cene i zarade (KGV) za Cosmos Pharmaceutical je trenutno 15,51. KGV poredi sadašnju cenu akcije sa zaradom po akciji i pomaže investitorima da procene valuaciju akcije Cosmos Pharmaceutical.

Odnos cene i prihoda (KUV) za Cosmos Pharmaceutical je trenutno 0,45. KUV poredi tržišnu kapitalizaciju sa godišnjim prihodima i služi kao metrika valuacije za akciju Cosmos Pharmaceutical.

Eulpool score kvaliteta za Cosmos Pharmaceutical je 7/10.

ISIN za Cosmos Pharmaceutical je JP3298400007. ISIN (International Securities Identification Number) je globalno jedinstveni identifikator za hartije od vrednosti.

Ticker za Cosmos Pharmaceutical je 3349.T. Simbol tikera se koristi za trgovinu akcijama Cosmos Pharmaceutical na berzanskom tržištu.

Фер вредностTerminal
5.771,16 JPY
Над-/ПодцењеностTerminal
Адекватно вредна
Индустрија
Малопродаја намирница и основних потрошних добара
Број акција
Запослени
Приход по запосленом
259,34 М JPY
Раст прихода Ø5 година
Раст EBIT Ø5 година
Раст нето добити Ø5 година
Веб сајт cosmospc.co.jp
Земља
Валута
JPY
Јавна понуда
11. нов 2004.
ISIN
JP3298400007
CUSIP
J08959108
SEDOL
B036QP1
Тржишна капитализација
Опсег од 52 недеље
AAQS
7 / 10
PEG
3,91
P/E однос
P/Ee 2027
15,61
P/Ee 2028
14,75
P/Ee 2029
13,85
P/Ee 2030
13,72
P/Ee 2031
12,85
P/S
P/Se
0,42
EV/EBIT
12,14
P/B однос
1,75
ROE (Поврат на капитал)
ROA (Поврат на имовину)
ROCE (Поврат на ангажовани капитал)
ROIC (Поврат на уложени капитал)
8,85 %
Дивиденда
Прinos од дивиденде
1,31 %
Процењени принос од дивиденде
1,57 %
Стопа исплате
19,67 %
Раст дивиденде Ø5Y
14,73 %
Дивиденде по години
2
Дивиденда исплаћена од
21 година
Дивиденда није смањена од
13 година
Дивиденда повећана од
7 година
Порез на дивиденде
15,32 %
Zadnje ažurirano 22. нов 2026. 11:05

Cosmos Pharmaceutical Тикер

JPX · 3349.TOTC · CSMYF

Cosmos Pharmaceutical FIGI

3349:JP · BBG000Q2PV823349:JT · BBG000Q2PVC73349:JJ · BBG000Q2Q1C23349:JE · BBG000Q2Q2943349:JI · BBG000Q2Q2F7CSMYF:US · BBG000QVGL26CSMYF:PQ · BBG000QVGQC4CSMYF:UV · BBG000QVGQW23349:JU · BBG002QKDGZ43349:JW · BBG00875J0393349EUR:X2 · BBG00JYJW8N13349EUR:XB · BBG00JYJW8P9